Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines

被引:0
|
作者
Caroline Gest
Ulrich Joimel
Limin Huang
Linda-Louise Pritchard
Alexandre Petit
Charlène Dulong
Catherine Buquet
Chao-Quan Hu
Pezhman Mirshahi
Marc Laurent
Françoise Fauvel-Lafève
Lionel Cazin
Jean-Pierre Vannier
He Lu
Jeannette Soria
Hong Li
Rémi Varin
Claudine Soria
机构
[1] Université de Rouen,Laboratoire MERCI
[2] INSERM UMR-S 728, EA3829, Faculté de Médecine et de Pharmacie
[3] IUH,Department of Onco
[4] Hôpital Saint-Louis,Haematology, UMRS 872, CNRS, E 18, INSERM
[5] Université Paris-Sud and CNRS FRE 3377,undefined
[6] CEA-Saclay,undefined
[7] Université Paris VI,undefined
[8] INSERM U553,undefined
[9] Hôpital Saint-Louis,undefined
[10] Unité Fonctionnelle Oncologie Médicale,undefined
[11] Hôtel-Dieu,undefined
[12] Assistance Publique-Hôpitaux de Paris (AP-HP),undefined
[13] Unité Fonctionnelle Oncologie Médicale,undefined
[14] Hôtel-Dieu,undefined
[15] Assistance Publique-Hôpitaux de Paris (AP-HP),undefined
来源
BMC Cancer | / 13卷
关键词
Breast cancer; Cancer aggressiveness; Rac3 GTPases; ERK; NF-κB;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Comparison the cytotoxic effects of Ulva fasciata and Ulva lactuca on the MCF-7 and MDA-MB-231 breast cancer cell lines
    Moulazadeh, Alireza
    Ranjbar, Razieh
    Hekmat, Maryam
    Sedaghat, Fatemeh
    Yousefzadi, Morteza
    Najafipour, Sohrab
    PHYSIOLOGY AND PHARMACOLOGY, 2020, 25 (04): : 373 - 383
  • [32] Screening of Specific and Common Pathways in Breast Cancer Cell Lines MCF-7 and MDA-MB-231 Treated with Chlorophyllides Composites
    Huang, Keng-Shiang
    Wang, Yi-Ting
    Byadgi, Omkar
    Huang, Ting-Yu
    Tai, Mi-Hsueh
    Shaw, Jei-Fu
    Yang, Chih-Hui
    MOLECULES, 2022, 27 (12):
  • [33] Biological activity of Haematoxylum brasiletto in MCF7 and MDA-MB-231 breast cancer cell lines
    Bello-Martinez, GeorginaVenecia
    Garcia-Ramirez, Genesis
    Olea-Flores, Monserrat
    Navarro-Tito, Napoleon
    Hernandez-Moreno, Alberto
    Avila-Caballero, Luz Patricia
    Torres-Moreno, Heriberto
    Bello-Martinez, Jorge
    SOUTH AFRICAN JOURNAL OF BOTANY, 2022, 146 : 528 - 537
  • [34] Metabolism of equilenin in MCF-7 and MDA-MB-231 human breast cancer cells
    Spink, DC
    Zhang, F
    Hussain, MM
    Katz, BH
    Liu, XM
    Hilker, DR
    Bolton, JL
    CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (05) : 572 - 581
  • [35] Nutraceutical-induced ribotoxic stress in MCF-7, MDA-MB-231 and SK-BR-3 breast cancer cell lines
    Wnuk, M.
    Adamczyk, J.
    Deregowska, A.
    Bednarz, D.
    Lewinska, A.
    FEBS JOURNAL, 2016, 283 : 388 - 388
  • [36] Bag-1 induces cell survival in MDA-MB-231 breast cancer cell lines
    Kizilboga, T.
    Ozden, C.
    Doganay, G. Dinler
    FEBS JOURNAL, 2016, 283 : 227 - 227
  • [37] Echinacea Angustifolia DC Extract Induces Apoptosis and Cell Cycle Arrest and Synergizes with Paclitaxel in the MDA-MB-231 and MCF-7 Human Breast Cancer Cell Lines
    Abraham Espinosa-Paredes, Daniel
    Cornejo-Garrido, Jorge
    Adan Moreno-Eutimio, Mario
    Pablo Martinez-Rodriguez, Oswaldo
    Eugenia Jaramillo-Flores, Maria
    Ordaz-Pichardo, Cynthia
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2021, 73 (11-12): : 2287 - 2305
  • [38] Effect of transforming growth factor-β1 on oestrogen metabolism in MCF-7 and MDA-MB-231 breast cancer cell lines
    Ee, YS
    Lai, LC
    Reimann, K
    Lim, PKC
    ONCOLOGY REPORTS, 1999, 6 (04) : 843 - 846
  • [39] In vitro investigation of cytotoxic and antioxidative activities of Ardisia crispa against breast cancer cell lines, MCF-7 and MDA-MB-231
    Nordin, Muhammad Luqman
    Kadir, Arifah Abdul
    Zakaria, Zainul Amiruddin
    Abdullah, Rasedee
    Abdullah, Muhammad Nazrul Hakim
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 18
  • [40] Melatonin has an inhibitory effect on MCF-7 and MDA-MB-231 human breast cancer cell lines by inducing autophagy and apoptosis
    Onder, Gozde Ozge
    Sezer, Gulay
    Ozdamar, Saim
    Yay, Arzu
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 (06) : 1038 - 1056